What is CJC 1295+ IMPAMORELIN Blend (5/10mg)
CJC-1295+ IMPAMORELIN is a combined GHRH analog + ghrelin receptor agonist designed to support pulsatile and sustained GH release in controlled laboratory models.
Potential Research Effects
• Synergistic growth hormone secretion (GHRH + GHSR pathways)
• Increased circulating IGF-1 in experimental settings
• Support for lean mass accrual and recovery kinetics
• Sleep architecture and tissue repair exploration
• Lipid metabolism and energy regulation research
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
